Adjuvants Derived from Neisseria meningitidis Serogroup B Induce a Cross Reactive Response against Neisseria gonorrhoeae in Mice
Open Access
- 1 January 2020
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in Open Journal of Immunology
- Vol. 10 (03), 47-58
- https://doi.org/10.4236/oji.2020.103005
Abstract
Introduction: Neisseria is a large genus of bacteria that colonize mucosal surfaces. Of the 11 species that colonize humans, only two are pathogens, N. meningitidis and N. gonorrhoeae. Both are obligate human pathogens; the last is causal agent of gonorrhea disease. Although curable with timely antibiotic treatment, an annual incidence of more than 62 million cases is estimated by the World Health Organization and there are no successful vaccines available. In contrast, several prophylactic vaccine options for Neisseria meningitidis meningitis do exist. Of note, there is trace of cross parenteral response induced between N. meningitidis and N. gonorrhoeae, and Proteoliposome (PL, also named outer membrane vesicles, OMV) vaccine has shown high impact on this response. Objective: To determine effect of VAMENGOC-BC? and its derivates (AFPL1 and AFCo1) at mucosal and systemic level and possible cross response against Neisseria gonhorroeae in Balb/c and C57Bl/6 mice. Methods: We evaluated cross response against N. gonorrhoeae in mouse serum IgG and saliva IgA after mucosal immunization with VA-MENGOC-BC or its derivatives (AF, Adjuvant Finlay PL1 or AFCo (cochleate) 1). Results: Immunizations with AFPL1 or AFCo1 induce anti N. gonorrhoeae at saliva IgA and serum IgG responses similar to VA-MENGOC-BC? vaccine. Conclusions: Such data confirms a new possible window of prime-boost vaccination strategy against gonorrhea and extends our knowledge regarding the effect of PL vaccines on cross responses.Keywords
This publication has 24 references indexed in Scilit:
- Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant PlatformFrontiers in Immunology, 2013
- Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: A road map for discovering new antigensHuman Vaccines, 2009
- Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in miceVaccine, 2007
- New Vaccines Require Potent Adjuvants like AFPL1 and AFCo1Scandinavian Journal of Immunology, 2007
- Vaccination of Mice with Gonococcal TbpB Expressed In Vivo from Venezuelan Equine Encephalitis Viral Replicon ParticlesInfection and Immunity, 2006
- Analysis ofNeisseria lactamicaantigens putatively implicated in acquisition of natural immunity toNeisseria meningitidisFEMS Immunology & Medical Microbiology, 2002
- Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC VaccineInfection and Immunity, 2001
- Generation of Female Genital Tract Antibody Responses by Local or Central (Common) Mucosal ImmunizationInfection and Immunity, 2000
- Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virusVaccine, 1995
- Antigenic relationships of transferrin-binding proteins fromNeisseria meningitisis, N. gonorrhoeaeandHaemophilus influenzae: Cross-reactivity of antibodies to NH2-terminal peptidesFEMS Microbiology Letters, 1993